Kindred Biosciences to Announce First Quarter 2021 Financial Results
Kindred Biosciences, Inc. (NASDAQ: KIN) will release its Q1 2021 financial results on May 11, 2021, after market close. The company aims to improve pet health with innovative biologics, leveraging human medicine safety and efficacy. A conference call will be held at 4:30 p.m. Eastern where analysts can discuss the results. Interested parties may join by calling 855-433-0927 in the U.S. or 484-756-4262 internationally, using conference ID 7573679. The call will also be webcast live, with replays available for 30 days.
- Kindred Biosciences is focused on developing innovative drugs for pets, enhancing their health and wellbeing.
- The company has a deep pipeline of biologics across various therapeutic classes.
- None.
SAN FRANCISCO, May 3, 2021 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, will release its first quarter 2021 financial results on May 11, 2021, after the market close. The Company will host a conference call at 4:30 p.m. Eastern time/1:30 p.m. Pacific time that day.
Access the call by dialing toll-free (855) 433-0927 from the U.S. or (484) 756-4262 internationally, and using conference ID 7573679.
The call will also be webcast live here, with a replay available at that link for 30 days.
About Kindred Biosciences
Kindred Biosciences is a biopharmaceutical company developing innovative biologics focused on saving and improving the lives of pets. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The company's strategy is to identify targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated targets for dogs and cats. KindredBio has a deep pipeline of novel biologics in development across many therapeutic classes, alongside state-of-the-art biologics manufacturing capabilities and a broad intellectual property portfolio.
For more information, visit: www.kindredbio.com
Contact
Katja Buhrer
katja.buhrer@kindredbio.com
(917) 969-3438
View original content to download multimedia:http://www.prnewswire.com/news-releases/kindred-biosciences-to-announce-first-quarter-2021-financial-results-301281866.html
SOURCE Kindred Biosciences, Inc.
FAQ
When will Kindred Biosciences announce its Q1 2021 financial results?
What time is the Kindred Biosciences conference call for Q1 2021 results?
How can I access the Kindred Biosciences Q1 2021 financial results call?
Is there a webcast available for the Kindred Biosciences conference call?
